Chemotherapy Naive
Showing 1 - 25 of >10,000
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United
Recruiting
- Hormone-Resistant Prostate Cancer
- +3 more
-
Ann Arbor, Michigan
- +3 more
Feb 2, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston
Completed
- Castration-Resistant Prostate Carcinoma
- +5 more
- Durvalumab
- Tremelimumab
-
Houston, TexasM D Anderson Cancer Center
Nov 9, 2022
HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients Trial (PERT-IJS plus trastuzumab,
Not yet recruiting
- HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
- PERT-IJS plus trastuzumab, carboplatin and docetaxel
- Perjeta plus trastuzumab, carboplatin and docetaxel
- (no location specified)
Sep 21, 2023
Medicines Called Enzalutamide and Abiraterone in People With
Not yet recruiting
- Prostatic Neoplasms, Castration-Resistant
- Enzalutamide
- Abiraterone acetate
-
New York, New YorkPfizer Inc
Jul 21, 2023
Biliary Tract Tumors Trial in Seoul (Durvalumab, Tremelimumab, Gemcitabine)
Active, not recruiting
- Biliary Tract Neoplasms
- Durvalumab
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 26, 2021
Carcinoma, Hepatocellular, Hepatoma Trial in Seongnam, Seoul (Regorafenib/Nivolumab)
Completed
- Carcinoma, Hepatocellular
- Hepatoma
-
Seongnam, Korea, Republic of
- +2 more
Dec 4, 2022
NSCLC Stage IV Trial in Spain (Atezolizumab)
Completed
- Non-small Cell Lung Cancer Stage IV
-
Elche, Alicante, Spain
- +14 more
Jan 26, 2023
NSCLC Trial in China (Atezolizumab, Placebo, Bevacizumab)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Atezolizumab
- +5 more
-
Beijing City, China
- +22 more
Dec 7, 2022
Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)
Active, not recruiting
- Non-muscle-invasive Bladder Cancer
- Gemcitabine 1000 mg, Docetaxel 37.5g
-
Zagreb, CroatiaUniversity Hospital Centre Zagreb
Jan 20, 2023
Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell Trial run by the NCI (Alemtuzumab (Campath), EPOCH)
Completed
- Lymphoma, T-Cell
- Lymphoma, Extranodal NK-T-Cell
- Alemtuzumab (Campath)
- EPOCH
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 3, 2022
Locally Advanced or Metastatic Pancreatic Cancer Trial (S-1)
Completed
- Locally Advanced or Metastatic Pancreatic Cancer
- (no location specified)
Nov 9, 2021
Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)
Not yet recruiting
- Lung Adenocarcinoma
- +3 more
- Serplulimab and Bevacizumab injection
- (no location specified)
Dec 21, 2022
Small Cell Lung Carcinoma Trial in Goyang-si (IP chemo, IP chemo plus simvastatin)
Active, not recruiting
- Small Cell Lung Carcinoma
- IP chemotherapy
- IP chemotherapy plus simvastatin
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center , Korea
Apr 4, 2022
Prostate Cancer Trial in Riga (ODM-201 Tablet A, ODM-201 Tablet B, ODM-201 capsule formulation)
Completed
- Prostate Cancer
- ODM-201 Tablet A
- +2 more
-
Riga, LatviaP. Stradina Clinical University Hospital
Mar 16, 2021
Patients With Advanced Treatment Naive LCNEC Trial in Tel Aviv (Durvalumab)
Recruiting
- Patients With Advanced Treatment Naive LCNEC
-
Tel Aviv, IsraelAssuta MC
Feb 20, 2022
Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)
Recruiting
- Metastatic Hormone Naive Prostate Cancer
-
Sydney, New South Wales, Australia
- +4 more
Nov 4, 2022
Carcinoma, Small Cell Trial in Hwasun (Belotecan, Etoposide, Cisplatin)
Completed
- Carcinoma, Small Cell
- Belotecan
- +2 more
-
Hwasun, Korea, Republic ofChonnam National University Hwasun Hospital
Aug 2, 2021
Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)
Recruiting
- Extensive Stage Small Cell Lung Cancer
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Jun 6, 2023
Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Prostatic Tumor Trial in Canada, United States (I-131-1095,
Active, not recruiting
- Metastatic Prostate Cancer
- +4 more
-
Duarte, California
- +26 more
Aug 3, 2022
NSCLC Trial in Worldwide (Atezolizumab, Tiragolumab, Placebo)
Active, not recruiting
- Non-small Cell Lung Cancer
- Atezolizumab
- +2 more
-
Tempe, Arizona
- +40 more
Nov 11, 2022
Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)
Not yet recruiting
- Small Cell Lung Cancer Extensive Stage
- IN10018
- +3 more
-
Jinan, China
- +2 more
Sep 10, 2023
Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma Trial in Houston (Fine-Needle Aspiration, Irinotecan, Irinotecan
Withdrawn
- Metastatic Ewing Sarcoma
- Recurrent Ewing Sarcoma
- Fine-Needle Aspiration
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 1, 2022